| No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
| 1 |
rs111755602 |
chr21:15407158-15407159 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 2 |
rs2822387 |
chr21:15407163-15407164 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 3 |
rs192653120 |
chr21:15407191-15407192 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 4 |
rs533201861 |
chr21:15407231-15407232 |
Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 5 |
rs546709881 |
chr21:15407247-15407248 |
Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 6 |
rs113810004 |
chr21:15407312-15407313 |
Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 7 |
rs184323146 |
chr21:15407373-15407374 |
Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 8 |
rs117743509 |
chr21:15407381-15407382 |
Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 9 |
rs535551820 |
chr21:15407397-15407398 |
Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 10 |
rs142428731 |
chr21:15407398-15407399 |
Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 11 |
rs113227413 |
chr21:15407480-15407481 |
Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 12 |
rs146442251 |
chr21:15407532-15407533 |
Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 13 |
rs75485214 |
chr21:15407534-15407535 |
Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 14 |
rs558472654 |
chr21:15407559-15407560 |
Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 15 |
rs112617238 |
chr21:15407572-15407573 |
Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 16 |
rs187972129 |
chr21:15407574-15407575 |
Weak transcription Transcr. at gene 5' and 3' Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 17 |
rs534357743 |
chr21:15407621-15407622 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 18 |
rs111288785 |
chr21:15407656-15407657 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 19 |
rs192648461 |
chr21:15407708-15407709 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 20 |
rs138990618 |
chr21:15407711-15407712 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 21 |
rs143318822 |
chr21:15407714-15407715 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 22 |
rs118083936 |
chr21:15407790-15407791 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 23 |
rs200180008 |
chr21:15407817-15407818 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 24 |
rs74633608 |
chr21:15407850-15407851 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 25 |
rs184742194 |
chr21:15407853-15407854 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 26 |
rs113627488 |
chr21:15407870-15407871 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 27 |
rs544167677 |
chr21:15407872-15407873 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 28 |
rs74514489 |
chr21:15407939-15407940 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 29 |
rs533078563 |
chr21:15407973-15407974 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 30 |
rs540386158 |
chr21:15408031-15408032 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 31 |
rs2822388 |
chr21:15408034-15408035 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
| 32 |
rs150473944 |
chr21:15408059-15408060 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 33 |
rs188757964 |
chr21:15408060-15408061 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 34 |
rs568753261 |
chr21:15408111-15408112 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 35 |
rs372654697 |
chr21:15408112-15408113 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 36 |
rs531385010 |
chr21:15408147-15408148 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 37 |
rs551094223 |
chr21:15408148-15408149 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 38 |
rs138319565 |
chr21:15408195-15408196 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 39 |
rs78367165 |
chr21:15408202-15408203 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 40 |
rs149622142 |
chr21:15408272-15408273 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 41 |
rs144337709 |
chr21:15408333-15408334 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 42 |
rs181446053 |
chr21:15408396-15408397 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 43 |
rs552485567 |
chr21:15408418-15408419 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 44 |
rs559396913 |
chr21:15408488-15408489 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 45 |
rs556279114 |
chr21:15408523-15408524 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 46 |
rs576354342 |
chr21:15408541-15408542 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 47 |
rs139246997 |
chr21:15408546-15408547 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 48 |
rs112630564 |
chr21:15408552-15408553 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 49 |
rs558688863 |
chr21:15408585-15408586 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
| 50 |
rs374950431 |
chr21:15408589-15408590 |
Weak transcription Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|